Biotechnology investors, armed with troves of data and “misfit” minds, have become key-decision makers in everything from when to open up the states to which medicines can turn the tide in this pandemic the quickest. As the BIO Investor Forum kicks off virtually today, a biomedical renaissance has Wall Street bullish on biotech’s future.

Overcrowded hospitals during the pandemic can pose treatment challenges for patients with other serious illnesses. As Kite Pharma CEO Christi Shaw says, “Cancer doesn’t stop in a crisis.” Neither do her company’s employees, who go to extraordinary lengths to get personalized CAR-T treatments to patients around the world.

Hosted by Jim Greenwood.

The I AM BIO podcast with host Dr. Michelle McMurry-Heath explores the search for biotechnology breakthroughs and our progress in ending the pandemic, helping patients and carrying the mantle for science and sustainability.

The ability to produce COVID vaccines in record time only scratches the surface of what synthetic biology can do. Gingko Bioworks out of Boston is now 3-D printing millions of letters of DNA code and then using CRISPR to insert them into living cells, transforming what’s scientifically possible.

Two potentially deadly respiratory viruses — the coronavirus and the influenza virus — will test our health care system and American common sense this fall. As millions return to school, campus and work this fall, the 2020 flu season is shaping up to be something of a pandemic pressure test for our nation. Vaccinations, social distancing and mask-wearing will be the key to containing both flu and COVID and saving countless lives.

Guest hosted by Phyllis Arthur.

Need a dose of inspiration in a time of national tragedy? A remarkable biotech breakthrough from Global Blood Therapeutics offers fresh hope to patients living with sickle-cell disease.

For years, leaders on the Bipartisan Commission on Biodefense told Congress and the White House that it wasn’t a matter of if, but when, a pandemic would happen. Exploring the panel’s unheeded recommendations can give the United States a blueprint for what to do going forward to protect us from the coronavirus and future threats.

The pandemic has unleashed overwhelming levels of fear, isolation, anxiety and loss in our society. A CDC mental health survey this summer found that 1 in 10 people had “seriously considered” suicide within the last month. As America comes to grips with the severity of our ongoing mental health crisis, telepsychiatry has emerged as a virtual lifeline to help patients access treatment from home.

The engine powering Maryland vaccine maker Novavax is a recombinant nanoparticle platform that is impressing vaccinologists as well as government and nonprofit funders. Learn about the innovative biotech generating big buzz in the global covid vaccine race.

Patients with autoimmune diseases like lupus and rheumatoid arthritis have been forced to ration or skip doses of hydroxychloroquine during the pandemic due to shortages caused by off-label prescribing. Yet despite multiple FDA clinical studies that concluded the drug offers no clinical benefit against covid and may increase dangerous side effects; President Trump continues to use the bully pulpit to suggest otherwise. It's not like autoimmune patients — at greater risk of serious COVID disease, stress-induced flare-ups and vaccine complications — didn’t have enough to worry about already.